| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 10/02/2001 | US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists |
| 10/02/2001 | US6297264 E.g., 4-(2-benzyloxy-2-(3-cyclopentyloxy-4-methoxyphenyl)ethyl)pyrid ine; phosphodiesterase inhibitors |
| 10/02/2001 | US6297262 Use of 5-(2-ethyl-2h-tetrazol-5-yl)-1,2,3,6-tetrahydro-1-methylpyridi ne |
| 10/02/2001 | US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297257 Benzazine derivatives phosphodiesterase 4 inhibitors |
| 10/02/2001 | US6297254 Method for the prevention or treatment of a motoneuron disease |
| 10/02/2001 | US6297253 Inactivating a nuclear localization signal of a protein comprising contacting the protein with an aryl carbonyl compound that forms stable reversible covalent interactions with neighboring basic amino acid residues |
| 10/02/2001 | US6297252 Treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory. |
| 10/02/2001 | US6297250 Useful for inhibiting transport of nucleosides or purines across cell membranes, thereby to potentiate the activity of various cytotoxic antitumor drugs |
| 10/02/2001 | US6297246 Benzoxazole derivatives; does not cause constipation as a side effect. |
| 10/02/2001 | US6297245 Cisplatin and folic acid administered to treat breast cancer |
| 10/02/2001 | US6297244 Stable drug composition |
| 10/02/2001 | US6297243 Methods of treating hot flashes, estrogen deficiencies and deferring menopause by the administration of a luteinizing hormone antagonist |
| 10/02/2001 | US6297240 Particularly diseases caused by elevated intro-ocular pressure, such as ocular hypertension and glaucoma |
| 10/02/2001 | US6297239 Inhibitors of prenyl-protein transferase |
| 10/02/2001 | US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases |
| 10/02/2001 | US6297236 Synergistic combination of 1-(dimethylisoxazolylsulfonyl)-2-halo-5,6 -difluoromethylenedioxybenzimidazole and methylformoxime substituted with dioxazinyl and a fluorodioxypyrimidinylphenyl group |
| 10/02/2001 | US6297235 Triazolopyridazine derivatives for treating anxiety and enhancing cognition |
| 10/02/2001 | US6297233 Lactam inhibitors of FXa and method |
| 10/02/2001 | US6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments |
| 10/02/2001 | US6297229 Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis |
| 10/02/2001 | US6297228 Use of angiostatic steroids in photodynamic therapy |
| 10/02/2001 | US6297227 Administering a corticosteroid. preferred corticosteroids are mometasone furoate and mometasone furoate monohydrate. |
| 10/02/2001 | US6297226 Treating a disease or a condition in a mammal treatable by inhibiting the activity of a monoamine oxidase |
| 10/02/2001 | US6297225 Treatment of highly vascular tumors |
| 10/02/2001 | US6297224 Method for treatment, preventing and reduction of elevated serum metabolite levels |
| 10/02/2001 | US6297223 Administering 5-substituted- or 5,6-dihydro-5-substituted-uracil derivative or a prodrug thereof; in conjunction with 5-fluorouracil or pro-drug thereof. |
| 10/02/2001 | US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter |
| 10/02/2001 | US6297220 Recombinant adenovirus comprising a dna sequence that codes for a gene product is delivered to a cardiac or vascular smooth muscle cell and the cell is maintained until that gene product is expressed. |
| 10/02/2001 | US6297218 Phospholipid complexes prepared from extracts of Vitis vinifera as anti-atherosclerotic agents |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |
| 10/02/2001 | US6297043 Molecular formula of c28 h20 o12; culture product from streptomyces which inhibits glucose-6-phosphate translocase; antidiabetic agents |
| 10/02/2001 | US6297039 Amps from Streptococcus pneumoniae |
| 10/02/2001 | US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 10/02/2001 | US6297028 IL-2R-associated polypeptide and DNA molecules coding therefor |
| 10/02/2001 | US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1 |
| 10/02/2001 | US6297015 Crohn's disease diagnostic and treatment methods and compositions |
| 10/02/2001 | US6297011 Mammalian tolloid-like gene and protein |
| 10/02/2001 | US6297003 Methods for the detection of a novel hepatitis C virus (HCV) terminal 3′ noncoding region |
| 10/02/2001 | US6296882 Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil |
| 10/02/2001 | US6296877 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 10/02/2001 | US6296876 Resistance to dissolution in acid media and dissolves rapidly in neutral to alkaline media; storage stability |
| 10/02/2001 | US6296875 Method for producing a granule |
| 10/02/2001 | US6296874 For therapy of diabetes |
| 10/02/2001 | US6296872 Tablet composition of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine |
| 10/02/2001 | US6296871 Stable solid pharmaceutical compositions containing enalapril maleate |
| 10/02/2001 | US6296861 Topically applying combination of conjugated linoleic acid and fatty acid esters of ascorbic acid to treat skin damage, such as contact dermatitis, atopic dermatitis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation burns |
| 10/02/2001 | US6296856 Topically applying to the skin of such organism, a cutaneous aging-inhibitorycosmetic/pharmaceutical/dermatological composition suited to promote desquamation of mammalian skin and/or to stimulate epidermal renewal |
| 10/02/2001 | US6296851 For screening antibiotics |
| 10/02/2001 | US6296847 Composition for treating benign prostatic hypertrophy |
| 10/02/2001 | US6296833 Administering compound that binds with specificity to a calcium-sensing receptor (car) and that is labeled with an agent that allows compound to be detected using in vivo imaging techniques; comparing; determining abnormal growth |
| 10/02/2001 | CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof |
| 10/02/2001 | CA2234567C Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
| 10/02/2001 | CA2207835C New derivatives of 3-(piperid-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole, their preparation processes and the pharmaceutical compositions they contain |
| 10/02/2001 | CA2159626C Method for delivering beneficial compositions to hair follicles |
| 10/02/2001 | CA2156908C C9 taxane derivatives and pharmaceutical compositions containing them |
| 10/02/2001 | CA2076647C Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them |
| 10/02/2001 | CA2054368C Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use |
| 10/02/2001 | CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| 09/27/2001 | WO2001071309A2 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | WO2001071029A1 Diagnosis of a person's risk of developing alcoholism |
| 09/27/2001 | WO2001071022A2 Lpa receptor agonists and antagonists and methods of use |
| 09/27/2001 | WO2001071017A2 Modified nodavirus rna for gene delivery |
| 09/27/2001 | WO2001071007A2 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001070982A2 Brca-1 regulators and methods of use |
| 09/27/2001 | WO2001070978A2 Polypeptides and nucleic acids encoding same |
| 09/27/2001 | WO2001070955A2 Identification of essential genes in prokaryotes |
| 09/27/2001 | WO2001070953A2 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 09/27/2001 | WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070767A2 Therapeutic anti-melanoma compounds |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070755A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 09/27/2001 | WO2001070754A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070753A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| 09/27/2001 | WO2001070748A1 THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS |
| 09/27/2001 | WO2001070747A1 Process for producing camptothecin |
| 09/27/2001 | WO2001070746A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 09/27/2001 | WO2001070745A1 Pyranoindoles for treating glaucoma |
| 09/27/2001 | WO2001070744A2 Process for the preparation of midazolam |
| 09/27/2001 | WO2001070742A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents |
| 09/27/2001 | WO2001070741A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| 09/27/2001 | WO2001070740A1 Process for preparing crystalline form i of cabergoline |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070733A2 Di-substituted iminoheterocyclic compounds |
| 09/27/2001 | WO2001070732A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070731A1 Decahydro-isoquinolines |
| 09/27/2001 | WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 09/27/2001 | WO2001070723A1 Benzothiophene derivatives and medicinal use thereof |
| 09/27/2001 | WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070718A1 Taxane anticancer agents |
| 09/27/2001 | WO2001070716A1 A process for the preparation of epothilone analogs and intermediates |
| 09/27/2001 | WO2001070709A2 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity |